JP2005501863A5 - - Google Patents

Download PDF

Info

Publication number
JP2005501863A5
JP2005501863A5 JP2003522566A JP2003522566A JP2005501863A5 JP 2005501863 A5 JP2005501863 A5 JP 2005501863A5 JP 2003522566 A JP2003522566 A JP 2003522566A JP 2003522566 A JP2003522566 A JP 2003522566A JP 2005501863 A5 JP2005501863 A5 JP 2005501863A5
Authority
JP
Japan
Prior art keywords
acid
delivery system
mixture
milk
apoprotein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003522566A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005501863A (ja
JP4532900B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IE2002/000121 external-priority patent/WO2003018049A2/en
Publication of JP2005501863A publication Critical patent/JP2005501863A/ja
Publication of JP2005501863A5 publication Critical patent/JP2005501863A5/ja
Application granted granted Critical
Publication of JP4532900B2 publication Critical patent/JP4532900B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003522566A 2001-08-23 2002-08-20 細菌またはウイルス感染症の予防または治療における乳清アポタンパク質の使用 Expired - Fee Related JP4532900B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IES20010780 2001-08-23
PCT/IE2002/000121 WO2003018049A2 (en) 2001-08-23 2002-08-20 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection

Publications (3)

Publication Number Publication Date
JP2005501863A JP2005501863A (ja) 2005-01-20
JP2005501863A5 true JP2005501863A5 (cg-RX-API-DMAC7.html) 2006-01-05
JP4532900B2 JP4532900B2 (ja) 2010-08-25

Family

ID=11042830

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003522566A Expired - Fee Related JP4532900B2 (ja) 2001-08-23 2002-08-20 細菌またはウイルス感染症の予防または治療における乳清アポタンパク質の使用

Country Status (15)

Country Link
US (2) US7687074B2 (cg-RX-API-DMAC7.html)
EP (1) EP1427436B1 (cg-RX-API-DMAC7.html)
JP (1) JP4532900B2 (cg-RX-API-DMAC7.html)
KR (1) KR100907959B1 (cg-RX-API-DMAC7.html)
CN (1) CN1578670B (cg-RX-API-DMAC7.html)
AT (1) ATE399562T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002356112B2 (cg-RX-API-DMAC7.html)
CA (1) CA2458146C (cg-RX-API-DMAC7.html)
DE (1) DE60227389D1 (cg-RX-API-DMAC7.html)
DK (1) DK1427436T3 (cg-RX-API-DMAC7.html)
ES (1) ES2309228T3 (cg-RX-API-DMAC7.html)
NZ (1) NZ531639A (cg-RX-API-DMAC7.html)
PT (1) PT1427436E (cg-RX-API-DMAC7.html)
RU (1) RU2305547C2 (cg-RX-API-DMAC7.html)
WO (1) WO2003018049A2 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2863168A1 (fr) * 2003-12-04 2005-06-10 Centre Nat Rech Scient Utilisation d'inducteurs de la voie de degradation de la gamma-butyrolactone pour inactiver le signal n-acy homoserine lactone.
AU2005262392A1 (en) * 2004-07-01 2006-01-19 Johnson & Johnson Vision Care, Inc. Compositions and methods for treating eye disorders and conditions
WO2007035870A2 (en) * 2005-09-20 2007-03-29 Prolacta Bioscience, Inc. A method for testing milk
PL1968627T3 (pl) 2005-11-18 2015-04-30 Glanbia Nutritionals Ireland Ltd Kompozycja do likwidacji biofilmu na ranach i hamowania jego odtwarzania
JP5017531B2 (ja) * 2006-09-11 2012-09-05 株式会社アップウェル 口内清浄剤
EP2229163A1 (en) * 2007-12-04 2010-09-22 Westgate Biological Limited Antimicrobial compositions comprising fatty acids and milk proteins
JP2009190994A (ja) * 2008-02-13 2009-08-27 Kitasato Institute 抗インフルエンザウイルス剤、及びその有効成分の製造方法
CN102149375B (zh) * 2008-06-11 2015-09-30 株式会社利根 人肾上腺素β3受体配体、含有其的食品及药品
US20090311236A1 (en) * 2008-06-11 2009-12-17 Immune @Work, Inc. Therapeutic Peptide Compositions And Methods Of Making And Using Same
US8808345B2 (en) * 2008-12-31 2014-08-19 Medtronic Ardian Luxembourg S.A.R.L. Handle assemblies for intravascular treatment devices and associated systems and methods
WO2010082587A1 (ja) * 2009-01-13 2010-07-22 株式会社大気倶楽部 空中懸濁物吸着剤
KR101119538B1 (ko) * 2009-06-10 2012-02-22 장선호 시알릭산-함유 유청 단백질을 유효성분으로 함유하는 인플루엔자 바이러스 감염증의 예방 및 치료용 조성물
CN102639129B (zh) 2009-11-17 2016-08-24 迈克尔·A·福兰 含游离脂肪酸的抗微生物组合物
AR082943A1 (es) * 2010-08-06 2013-01-23 Aptalis Pharma Ltd Formula nutricional predigerida
KR101355018B1 (ko) * 2010-12-13 2014-01-24 노부오 구보 시알릭산-함유 유청 단백질을 유효성분으로 함유하는 인플루엔자 바이러스 감염증의 예방용 동물사료 첨가제 및 이를 포함하는 동물사료용 조성물
RU2494726C2 (ru) * 2011-04-11 2013-10-10 Общество с Ограниченной Ответственностью "Производственная Торговая Компания "Лактив" Способ профилактики и лечения грибковой инфекции у больных с голосовыми протезами
EP3150257A1 (en) * 2015-09-30 2017-04-05 Buga, Doris A method for producing a composition for strengthening the immune system
US11291700B2 (en) 2017-12-05 2022-04-05 Nature's Delivery System, Llc Water-soluble cannabinoids and methods of making same
US11298379B2 (en) * 2020-04-16 2022-04-12 James F. Kane Compositions comprising milk fat globules and methods of making same
CN113855787A (zh) * 2020-06-30 2021-12-31 北京大学 乳清蛋白作为冠状病毒广谱抑制剂的用途

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2796378A (en) * 1954-04-09 1957-06-18 Jr Edgar A Ferguson Methionine free reaction product of a water-soluble copper salt and lactalbumin hydrolysate as fungicide
GB1050756A (cg-RX-API-DMAC7.html) * 1964-09-10 1900-01-01
US4397927A (en) * 1982-03-25 1983-08-09 Brog Roy A Imitation milk compositions and aqueous dispersions prepared therefrom
DE3661339D1 (en) * 1985-01-18 1989-01-12 Gauri Kailash Kumar Protein hydrolysates, production process and drugs containing th em
JPS62249931A (ja) 1986-04-21 1987-10-30 Morinaga Milk Ind Co Ltd 抗菌性組成物
JPH085798B2 (ja) * 1987-02-02 1996-01-24 紀夫 多田 抗菌剤
EP0402090B1 (en) * 1989-06-07 1993-09-01 Kao Corporation Edible oil-in water emulsion
JP2673320B2 (ja) 1990-01-25 1997-11-05 雪印乳業株式会社 う蝕原菌付着阻止剤
JPH04159232A (ja) * 1990-08-21 1992-06-02 Yakult Honsha Co Ltd 日和見感染症予防・治療用経口組成物
CA2094570A1 (en) * 1992-05-27 1993-11-28 Jerome F. Trumbetas Enzymatic protein process and product
CA2148261A1 (en) 1992-10-30 1994-05-11 Jerry A. Peterson Anti-diarrheic product and method of treating rotavirus-associated infection
US5785984A (en) * 1993-02-05 1998-07-28 Kao Corporation Taste-modifying method and bitterness-decreasing method
US6197356B1 (en) * 1993-08-03 2001-03-06 Immunopath Profile, Inc. Process for preparing hypoallergenic foods
WO1996004929A1 (en) * 1994-08-16 1996-02-22 Hemant Sabharwal Antibacterial composition containing multimeric alpha-lactalbumin
JP4233615B2 (ja) * 1996-08-22 2009-03-04 森永乳業株式会社 経口抗ヒト爪白癬及び/又は爪白癬以外のヒト足部白癬用医薬品
DE69824150T2 (de) * 1997-01-09 2005-05-25 Morinaga Milk Industry Co. Ltd. Lactoferrin-tabletten
IE970541A1 (en) 1997-07-25 1999-01-27 Michael Anthony Folan Maternal immune secretions and their use in the treatment and/or prophylaxis of the buccal cavity
JP4129566B2 (ja) * 1997-09-05 2008-08-06 大塚製薬株式会社 肝臓脂肪蓄積抑制組成物及び肝臓脂肪蓄積抑制用食品添加剤
US6287590B1 (en) 1997-10-02 2001-09-11 Esperion Therapeutics, Inc. Peptide/lipid complex formation by co-lyophilization
AUPP051497A0 (en) * 1997-11-24 1997-12-18 University Of Melbourne, The Antimicrobial peptides
US6126955A (en) * 1998-04-16 2000-10-03 University Of Utah Research Foundation Apo-transferrin as a potent inhibitor of bacterial adhesion to biomaterials
ATE259654T1 (de) 1998-06-26 2004-03-15 Nutricia Nv Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen
JP2000119257A (ja) * 1998-08-14 2000-04-25 Nippon Nohyaku Co Ltd ピリダジノン誘導体
GB9903584D0 (en) * 1999-02-18 1999-04-07 Univ Leeds Modified calycins
JP3662445B2 (ja) * 1999-06-30 2005-06-22 花王株式会社 油中水型乳化油脂組成物
EP1395124B1 (en) * 2001-05-23 2006-04-12 Nutricopia, Inc. Nutritional frozen dessert and methods of manufacture
US20030165606A1 (en) 2001-07-18 2003-09-04 Lasekan John B. Anti-regurgitation formula and uses thereof
EP1319407A1 (en) * 2001-12-14 2003-06-18 Montoie Import-Export S.A. Pharmaceutical composition for topical treatment of skin disorders and skin wounds

Similar Documents

Publication Publication Date Title
JP2011505415A5 (cg-RX-API-DMAC7.html)
RU2004108040A (ru) Применеие апопротеинов сыворотки молока в профилактике или лечении микробной или вирусной инфекции
EP0956013B1 (en) Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid
Thormar et al. The role of microbicidal lipids in host defense against pathogens and their potential as therapeutic agents
HUP0301107A2 (hu) Zsírsavak gyógyhatású kombinációi és alkalmazásuk
JP2011505415A (ja) 遊離脂肪酸のブレンド及びその使用
JPH0232017A (ja) 精神分裂症および/または関連した晩発性運動障害の治療のための薬剤を製造する方法
CN1099610A (zh) 用于吸烟者的制剂
US10149827B2 (en) Mixture of fatty acids and palmitoylethanolamide for use in the treatment of inflammatory and allergic pathologies
JPH10504016A (ja) サポニンをできれば他の化合物と組合せて含む炎症及び感染症の治療のための腸溶性配合物
US5914346A (en) Methods of treating animals to enhance natural killer lymphocyte function
US20240065998A1 (en) Monoacylglycerol and free fatty acid-based compositions, methods of manufacturing and use of the same
Bergsson et al. Antibacterial, antiviral and antifungal activities of lipids
CN115554320A (zh) 一株能够缓解牙周炎的发酵乳杆菌灭活菌体及其应用
JPH10500937A (ja) セサミン系リグナンの抗炎症及び感染防護効果
US7311925B2 (en) Methods and compositions for blocking microbial adherence to eukaryotic cells
Das Do unsaturated fatty acids function as endogenous antibacterial and antiviral molecules?
JP2019510745A5 (cg-RX-API-DMAC7.html)
JPH0759540A (ja) アラキドン酸含有健康食品
JP2009120519A (ja) 消化管潰瘍の予防又は治療剤
US20120213713A1 (en) Compositions of omega fatty acids for the prevention and treatment of dental caries resulting from oral infections
US20120213714A1 (en) Method and compositions as an adjunct for the prevention and treatment of periodontal disease
JPH06271464A (ja) 消化器系障害の予防または治療用アラキドン酸含有組成物
Kristmundsdóttir et al. Lipids as active ingredients in pharmaceuticals, cosmetics and health foods
US20120213715A1 (en) Method and composition for the prevention and treatment of early childhood dental caries